Literature DB >> 1623667

Cardiogenic hypertrophic osteoarthropathy.

M Martinez-Lavin1.   

Abstract

It has been a generally held notion that the association of cyanotic congenital heart diseases with hypertrophic osteoarthropathy (HOA) is exceptional. However, recent prospective studies have demonstrated the opposite to be true. More than a third of patients with cyanotic heart diseases have HOA. The skeletal changes are more prevalent, more persistent and more severe than in any other internal illness. The clinical features of cardiogenic HOA are here discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1623667

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

1.  Hypertrophic osteoarthropathy: endothelium and platelet function.

Authors:  F Silveri; R De Angelis; F Argentati; D Brecciaroli; S Muti; C Cervini
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

2.  Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate.

Authors:  Howard Amital; Yaakov H Applbaum; Lena Vasiliev; Alan Rubinow
Journal:  Clin Rheumatol       Date:  2004-05-20       Impact factor: 2.980

3.  Hypertrophic osteopathy in a cat with cardiac interventricular septal defect.

Authors:  Felipe Auatt Batista de Sousa; Matheus Viezzer Bianchi; Paula Augusto Taunde; Marcele Bettim Bandinelli; Rochana Rodrigues Fett; David Driemeier; Saulo Petinatti Pavarini
Journal:  J Vet Sci       Date:  2019-09       Impact factor: 1.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.